OBIO

6.5806.00%
DR

Darren R. Sherman

Founder, President, COO & Director

Mr. Darren R. Sherman is President, COO, Director & Founder at Health Sciences Acquisitions Corporation 2 (formerly known as Orchestra BioMed, Inc.) since May 2018. He served as a Managing Partner and Managing Director of Orchestra Medical Ventures, LLC. from 2009 to December 2019. Since May 2018, Mr. Sherman has been Chief Operations Officer and a Member of the Board of Orchestra BioMed Holdings, Inc. (formerly Known As Health Sciences Acquisitions Corporation 2) (formerly known as Orchestra BioMed, Inc.) and serves as its President. Mr. Sherman serves as the Chief Technical Officer of Accelerated Technologies, Inc. (ATI) as well as Chief Executive Officer of Caliber Therapeutics, Inc. From 2012 until March 2019 served as Chief Executive Officer and a Director of FreeHold Surgical, Inc. He has management and entrepreneurial experience in the medical technology industry spanning interventional cardiology, cardiac electrophysiology, sudden cardiac death, stroke and neurovascular therapies. Prior to joining Orchestra, he held various positions in executive management for Cordis Neurovascular (CNV) including Executive Director R&D and Director of Strategic Marketing for stroke products. He had worldwide responsibility for all neurovascular R&D and global strategic marketing responsibilities for the Stroke franchise, including budgets, portfolio of products and strategic planning. He made significant contributions to the design and commercialization of a series of key products including the Enterprise Vascular Reconstruction Device and the Orbit Embolic Coil as well as directed the filing of over 100 patents. He is the CEO and a Director of Caliber Therapeutics, Inc. from 2009 until March 2018. Prior to joining CNV, he played an integral role in the formation and development of Revivant Corp at Fogarty Engineering. He was Revivant's first Employee and managed the design, development and testing of the AutoPulse device from concept through market introduction. Along with the R&D related activities, he supported the clinical research, marketing and intellectual property efforts. Prior to Revivant, he held positions in research and development for Cardiac Pathways Corp. and Baxter Healthcare. In each of these companies, he participated in the creation, development and launch of products. Mr. Sherman has been a Director of Opco since 2015. He had been Independent Director of Motus GI Holdings Inc. since December 2016 until September 06, 2023. He served as a Director of MOTUS GI Medical Technologies Ltd since 2011 until September 2023. and serves as a Director of Vital Access Corp. From 2009 until March 2019 he served as a Director of BackBeat Medical, Inc. He served as a Director of Vivasure Medical Ltd from 2009 to 2016. Mr. Sherman has authored 45 U.S. patents with an additional 58 published applications. He earned a B.S. degree in Bioengineering from the University of California, San Diego.

Positions